Background illustration for clinical trials search

Paid Clinical Trials Iowa

Discover 657 paid clinical trials in Iowa. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM

for
Gestational Diabetes, Endothelial Dysfunction,
Location: Iowa City IA
Sponsor: Anna Stanhewicz, PhD

Sex: Female

Age: 18 - 50

Code: NCT06547619

Early_phase1, Recruiting

University of Iowa Interventional Psychiatry Service Patient Registry

for
Treatment Resistant Depression, Major Depressive Episode,
Location: Iowa City IA
Sponsor: Mark Niciu

Sex: All

Age: 18 - 70+

Code: NCT04480918

Recruiting

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

for
Acute Respiratory Distress Syndrome, ARDS
Location: Burlington MA, Springfield MA, Queens NY, Flushing NY,
Sponsor: Direct Biologics, LLC

Sex: All

Age: 18 - 70+

Code: NCT05354141

Phase3, Recruiting

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

for
Primary Biliary Cholangitis
Location: Boston MA, Quebec, New York NY, Manhasset NY, Montreal,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06051617

Phase3, Recruiting

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

for
Alpha1-Antitrypsin Deficiency
Location: Boston MA, New York NY, Newport VA, Hershey PA,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06165341

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Characterizing the Impact of Presbyphonia on Social Interaction

for
Presbyphonia
Location: Iowa City IA
Sponsor: Matthew R. Hoffman

Sex: All

Age: 65+

Code: NCT06441136

Recruiting

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

for
Cystic Fibrosis
Location: Boston MA, Valhalla NY, New York NY, Burlington VT,
Sponsor: Sonya Heltshe

Sex: All

Age: 0 - 10

Code: NCT04509050

Recruiting

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

for
Idiopathic Short Stature
Location: The Bronx NY, New York NY, Washington D.C. DC,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 3 - 11

Code: NCT06382155

Phase2, Recruiting

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

for
Non-cystic Fibrosis Bronchiectasis
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Sex: All

Age: 18 - 70+

Code: NCT06559150

Phase2, Recruiting

MMP-9 Inhibition for Recalcitrant Wet AMD

for
Exudative Macular Degeneration,
Location: Iowa City IA
Sponsor: University of Iowa

Sex: All

Age: 50 - 70+

Code: NCT04504123

Phase2, Recruiting

A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

for
Epilepsy, Temporal Lobe
Location: Syracuse NY, Charlottesville VA, Durham NC,
Sponsor: Neurona Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06422923

Phase1, Phase2, Recruiting

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

for
Growth Hormone Deficiency
Location: Manchester NH, Lebanon NH, New Hyde Park NY,
Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All

Age: 1 - 18

Code: NCT05775523

Recruiting

Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.

for
Recurrent Acute Pancreatitis
Location: Birmingham AL, Iowa City IA, Rochester MN
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 70+

Code: NCT06253117

Phase2, Recruiting

Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness

for
Hearing Loss, Unilateral, Deafness, Unilateral
Location: New York NY, Chapel Hill NC, Iowa City IA, Englewood CO,
Sponsor: Cochlear

Sex: All

Age: 5+

Code: NCT05318417

Recruiting

The Effects of the CF Carrier State on the Kidneys and Pancreas

for
Carrier State, Pancreatic Disease, Kidney Diseases
Location: Iowa City IA
Sponsor: Philip Polgreen

Sex: All

Age: 18 - 70+

Code: NCT05474417

Recruiting

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

for
NSCLC, Stage I
Location: New Brunswick NJ, Hershey PA, Richmond VA,
Sponsor: Greg Durm, MD

Sex: All

Age: 18+

Code: NCT04317534

Phase2, Recruiting

JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction

for
Patellar Dislocation, Recurrent, Patellar Dislocation,
Location: Boston MA, New York NY, Wake Forest NC, Gainesville FL,
Sponsor: Hospital for Special Surgery, New York

Sex: All

Age: 10 - 35

Code: NCT06883396

Recruiting

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

for
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma,
Location: The Bronx NY, New York NY, Hackensack NJ,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT05826535

Phase1, Phase2, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Boston MA, Lake Success NY, The Bronx NY, Brooklyn NY,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase3, Recruiting

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

for
Breast Cancer, Solid Tumors, Adult
Location: Boston MA, New York NY, Fairfax VA, Tampa FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05768139

Phase1, Phase2, Recruiting

Popular cities in Iowa

Offering a distinguished healthcare infrastructure and top class research institutions, Iowa has emerged as a significant base for a wide range of clinical trials. Major institutions such as the University of Iowa Hospitals and Clinics and the Holden Comprehensive Cancer Center are at the forefront of these studies, driving advancements in fields like oncology, cardiovascular research, and more. Iowa’s commitment to medical innovation and its growing network of research centers make it a developing hub in cutting-edge clinical trials.

Why choose Iowa for clinical trials?

Iowa offers distinct advantages for those participating in clinical trials. The state's distinct population, combined with its strong agricultural and rural communities, provides a diverse range of participants that enhances the accuracy and applicability of research findings. Iowa is also recognized for its innovative research environment and its cutting-edge medical advancements, driven by leading institutions such as the University of Iowa.

By choosing to participate in a clinical trial in Iowa, participants contribute to critical medical research while benefiting from a well-established and supportive clinical research infrastructure that promotes breakthroughs in patient care and treatment.

Common conditions studied in Iowa

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Iowa